Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma

Pediatric Blood and Cancer

Volumn 60, Issue 8, 2013, Pages 1267-1273

  Dantonello, Tobias M ^a   Int Veen, Christoph ^a   Schuck, Andreas ^b   Seitz, Guido ^c   Leuschner, Ivo ^d   Nathrath, Michaela ^e,f   Schlegel, Paul Gerhardt ^g   Kontny, Udo ^h   Behnisch, Wolfgang ⁱ   Veit Friedrich, Iris ^a   Kube, Stefanie ^a   Hallmen, Erika ^a   Kazanowska, Bernarda ^j   Ladenstein, Ruth ^k   Paulussen, Michael ^l,m   Ljungman, Gustaf ⁿ   Bielack, Stefan S ^a,o   Klingebiel, T ^p   Koscielniak, E ^a,c  

^a OLGAHOSPITAL   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g UNIVERSITY OF WÜRZBURG   (Germany)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j UNIVERSITY OF WROC AW   (Poland)

^k ST ANNA CHILDREN S HOSPITAL   (Austria)

^l UNIVERSITY OF BASEL   (Switzerland)

^m UNIVERSITY OF WITTEN HERDECKE   (Germany)

ⁿ UPPSALA UNIVERSITY   (Sweden)

^o UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^p GOETHE UNIVERSITY   (Germany)

more..

Author keywords

Alveolar rhabdomyosarcoma; Children; Recurrence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CHILD; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA, ALVEOLAR; SURVIVAL RATE; TIME FACTORS;

EID: 84879218517     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24488     Document Type: Article

References (29)

1. Weihkopf T, Blettner M, Dantonello T, et al. Incidence and time trends of soft tissue sarcomas in German children 1985-2004-A report from the population-based German Childhood Cancer Registry. Eur J Cancer 2008; 44:432-440.
2. Koscielniak E, Harms D, Henze G, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: A final report of the German cooperative soft tissue sarcoma study CWS-86. J Clin Oncol 1999; 17:3706-3719.
3. Dantonello TM, Int-Veen C, Harms D, et al. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol 2009; 27:1446-1455.
4. Enzinger FM, Shiraki M. Alveolar rhabdomyosarcoma: An analysis of 110 cases. Cancer 1969; 24:18-31.
5. Meza JL, Anderson J, Pappo AS, et al. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: The Children's Oncology Group. J Clin Oncol 2006; 24:3844-3851.
6. Dantonello TM, Int-Veen C, Winkler P, et al. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol 2008; 26:406-413.
7. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999; 341:342-352.
8. Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 1999; 17:3487-3493.
9. Chisholm JC, Marandet J, Rey A, et al. Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: A nomogram to better define patients who can be salvaged with further therapy. J Clin Oncol 2011; 29:1319-1325.
10. Mazzoleni S, Bisogno G, Garaventa A, et al. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer 2005; 104:183-190.
11. Koscielniak E, Jurgens H, Winkler K, et al. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study. Cancer 1992; 70:2557-2567.
12. Modritz D, Ladenstein R, Potschger U, et al. Treatment for soft tissue sarcoma in childhood and adolescence. Austrian results within the CWS 96 study. Wien Klin Wochenschr 2005; 117:196-209.
13. Asmar L, Gehan EA, Newton WA, et al. Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications. Cancer 1994; 74:2579-2588.
14. Harms D, Schmidt D, Treuner J. Soft-tissue sarcomas in childhood. A study of 262 cases including 169 cases of rhabdomyosarcoma. Z Kinderchir 1985; 40:140-145.
15. Klingebiel T, Pertl U, Hess CF, et al. Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 trial. Med Pediatr Oncol 1998; 30:269-275.
16. Harmer MH, editor. TNM classification of pediatric tumors. Geneva: Union International contre le Cancer; 1982. pp. 23-28.
17. Kaplan EL, Meyer P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
18. Greenwood M. Reports on public health and medical subjects. The errors of sampling of the survivorship tables. London: HM Stationery Office; 1926.
19. Flamant F, Rodary C, Rey A, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 1998; 34:1050-1062.
20. Raney RB, Jr., Crist WM, Maurer HM, et al. Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response. A report from the Intergroup Rhabdomyosarcoma Study I. Cancer 1983; 52:44-50.
21. Hayes-Jordan A, Doherty DK, West SD, et al. Outcome after surgical resection of recurrent rhabdomyosarcoma. J Pediatr Surg 2006; 41:633-638; discussion 633-638.
22. Lawrence W, Jr., Gehan EA, Hays DM, et al. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol 1987; 5:46-54.
23. Hays DM, Donaldson SS, Shimada H, et al. Primary and metastatic rhabdomyosarcoma in the breast: Neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol 1997; 29:181-189.
24. Persic M, Roberts JT. Alveolar rhabdomyosarcoma metastatic to the breast: Long-term survivor. Clin Oncol (R Coll Radiol) 1999; 11:417-418.
25. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 2001; 19:3091-3102.
26. Donaldson SS, Anderson JR. Rhabdomyosarcoma: Many similarities, a few philosophical differences. J Clin Oncol 2005; 23:2586-2587.
27. Mascarenhas L, Lyden ER, Breitfeld PP, et al. Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group. J Clin Oncol 2010; 28:4658-4663.
28. Mattke AC, Bailey EJ, Schuck A, et al. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas? Pediatr Blood Cancer 2009; 52:772-776.
29. Weigel BJ, Breitfeld PP, Hawkins D, et al. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma. J Pediatr Hematol Oncol 2001; 23:272-276.